Copyright Reports & Markets. All rights reserved.

Global Cyclotron for PET Drug Manufacturing Market Growth 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Cyclotron for PET Drug Manufacturing Consumption 2016-2026
    • 2.1.2 Cyclotron for PET Drug Manufacturing Consumption CAGR by Region
  • 2.2 Cyclotron for PET Drug Manufacturing Segment by Maximum Electron Energy
    • 2.2.1 ≤10 MeV
    • 2.2.2 11 ~20 MeV
    • 2.2.3 > 20 MeV
  • 2.3 Cyclotron for PET Drug Manufacturing Sales by Maximum Electron Energy
    • 2.3.1 Global Cyclotron for PET Drug Manufacturing Sales Market Share by Maximum Electron Energy (2016-2021)
    • 2.3.2 Global Cyclotron for PET Drug Manufacturing Revenue and Market Share by Maximum Electron Energy (2016-2021)
    • 2.3.3 Global Cyclotron for PET Drug Manufacturing Sale Price by Maximum Electron Energy (2016-2021)
  • 2.4 Cyclotron for PET Drug Manufacturing Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Research Institute
  • 2.5 Cyclotron for PET Drug Manufacturing Sales by Application
    • 2.5.1 Global Cyclotron for PET Drug Manufacturing Sale Market Share by Application (2016-2021)
    • 2.5.2 Global Cyclotron for PET Drug Manufacturing Revenue and Market Share by Application (2016-2021)
    • 2.5.3 Global Cyclotron for PET Drug Manufacturing Sale Price by Application (2016-2021)

3 Global Cyclotron for PET Drug Manufacturing by Company

  • 3.1 Global Cyclotron for PET Drug Manufacturing Sales Market Share by Company
    • 3.1.1 Global Cyclotron for PET Drug Manufacturing Sales by Company (2019-2021)
    • 3.1.2 Global Cyclotron for PET Drug Manufacturing Sales Market Share by Company (2019-2021)
  • 3.2 Global Cyclotron for PET Drug Manufacturing Revenue Market Share by Company
    • 3.2.1 Global Cyclotron for PET Drug Manufacturing Revenue by Company (2019-2021)
    • 3.2.2 Global Cyclotron for PET Drug Manufacturing Revenue Market Share by Company (2019-2021)
  • 3.3 Global Cyclotron for PET Drug Manufacturing Sale Price by Company
  • 3.4 Global Manufacturers Cyclotron for PET Drug Manufacturing Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Cyclotron for PET Drug Manufacturing Product Location Distribution
    • 3.4.2 Players Cyclotron for PET Drug Manufacturing Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 Cyclotron for PET Drug Manufacturing by Region

  • 4.1 Global Cyclotron for PET Drug Manufacturing by Region
    • 4.1.1 Global Cyclotron for PET Drug Manufacturing Sales by Region
    • 4.1.2 Global Cyclotron for PET Drug Manufacturing Revenue by Region
  • 4.2 Americas Cyclotron for PET Drug Manufacturing Sales Growth
  • 4.3 APAC Cyclotron for PET Drug Manufacturing Sales Growth
  • 4.4 Europe Cyclotron for PET Drug Manufacturing Sales Growth
  • 4.5 Middle East & Africa Cyclotron for PET Drug Manufacturing Sales Growth

5 Americas

  • 5.1 Americas Cyclotron for PET Drug Manufacturing Sales by Country
    • 5.1.1 Americas Cyclotron for PET Drug Manufacturing Sales by Country (2016-2021)
    • 5.1.2 Americas Cyclotron for PET Drug Manufacturing Revenue by Country (2016-2021)
  • 5.2 Americas Cyclotron for PET Drug Manufacturing Sales by Maximum Electron Energy
  • 5.3 Americas Cyclotron for PET Drug Manufacturing Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Cyclotron for PET Drug Manufacturing Sales by Region
    • 6.1.1 APAC Cyclotron for PET Drug Manufacturing Sales by Region (2016-2021)
    • 6.1.2 APAC Cyclotron for PET Drug Manufacturing Revenue by Region (2016-2021)
  • 6.2 APAC Cyclotron for PET Drug Manufacturing Sales by Maximum Electron Energy
  • 6.3 APAC Cyclotron for PET Drug Manufacturing Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Cyclotron for PET Drug Manufacturing by Country
    • 7.1.1 Europe Cyclotron for PET Drug Manufacturing Sales by Country (2016-2021)
    • 7.1.2 Europe Cyclotron for PET Drug Manufacturing Revenue by Country (2016-2021)
  • 7.2 Europe Cyclotron for PET Drug Manufacturing Sales by Maximum Electron Energy
  • 7.3 Europe Cyclotron for PET Drug Manufacturing Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Cyclotron for PET Drug Manufacturing by Country
    • 8.1.1 Middle East & Africa Cyclotron for PET Drug Manufacturing Sales by Country (2016-2021)
    • 8.1.2 Middle East & Africa Cyclotron for PET Drug Manufacturing Revenue by Country (2016-2021)
  • 8.2 Middle East & Africa Cyclotron for PET Drug Manufacturing Sales by Maximum Electron Energy
  • 8.3 Middle East & Africa Cyclotron for PET Drug Manufacturing Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Country

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Marketing, Distributors and Customer

  • 10.1 Sales Channel
    • 10.1.1 Direct Channels
    • 10.1.2 Indirect Channels
  • 10.2 Cyclotron for PET Drug Manufacturing Distributors
  • 10.3 Cyclotron for PET Drug Manufacturing Customer

11 Global Cyclotron for PET Drug Manufacturing Market Forecast

  • 11.1 Global Cyclotron for PET Drug Manufacturing Forecast by Region
    • 11.1.1 Global Cyclotron for PET Drug Manufacturing Forecast by Regions (2021-2026)
    • 11.2.2 Global Cyclotron for PET Drug Manufacturing Revenue Forecast by Regions (2021-2026)
  • 11.2 Americas Forecast by Country
  • 11.3 APAC Forecast by Region
  • 11.4 Europe Forecast by Country
  • 11.5 Middle East & Africa Forecast by Country
  • 11.6 Global Cyclotron for PET Drug Manufacturing Forecast by Maximum Electron Energy
  • 11.7 Global Cyclotron for PET Drug Manufacturing Forecast by Application

12 Key Players Analysis

  • 12.1 IBA
    • 12.1.1 IBA Company Information
    • 12.1.2 IBA Cyclotron for PET Drug Manufacturing Product Offered
    • 12.1.3 IBA Cyclotron for PET Drug Manufacturing Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.1.4 IBA Main Business Overview
    • 12.1.5 IBA Latest Developments
  • 12.2 Sumitomo
    • 12.2.1 Sumitomo Company Information
    • 12.2.2 Sumitomo Cyclotron for PET Drug Manufacturing Product Offered
    • 12.2.3 Sumitomo Cyclotron for PET Drug Manufacturing Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.2.4 Sumitomo Main Business Overview
    • 12.2.5 Sumitomo Latest Developments
  • 12.3 GE
    • 12.3.1 GE Company Information
    • 12.3.2 GE Cyclotron for PET Drug Manufacturing Product Offered
    • 12.3.3 GE Cyclotron for PET Drug Manufacturing Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.3.4 GE Main Business Overview
    • 12.3.5 GE Latest Developments
  • 12.4 Siemens
    • 12.4.1 Siemens Company Information
    • 12.4.2 Siemens Cyclotron for PET Drug Manufacturing Product Offered
    • 12.4.3 Siemens Cyclotron for PET Drug Manufacturing Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.4.4 Siemens Main Business Overview
    • 12.4.5 Siemens Latest Developments
  • 12.5 Advanced Cyclotron Systems
    • 12.5.1 Advanced Cyclotron Systems Company Information
    • 12.5.2 Advanced Cyclotron Systems Cyclotron for PET Drug Manufacturing Product Offered
    • 12.5.3 Advanced Cyclotron Systems Cyclotron for PET Drug Manufacturing Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.5.4 Advanced Cyclotron Systems Main Business Overview
    • 12.5.5 Advanced Cyclotron Systems Latest Developments

...

    13 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Cyclotron for PET Drug Manufacturing will have significant change from previous year. By the most conservative estimates of global Cyclotron for PET Drug Manufacturing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Cyclotron for PET Drug Manufacturing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of Cyclotron for PET Drug Manufacturing market by product type, application, key manufacturers and key regions and countries.

    Segmentation by maximum electron energy: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
    ≤10 MeV
    11 ~20 MeV
    > 20 MeV

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
    Hospital
    Research Institute

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
    IBA
    Sumitomo
    GE
    Siemens
    Advanced Cyclotron Systems
    Buy now